SCHEMBL6830990

SCHEMBL6830990

Cc1ccc(C(=O)Nc2cc[c]c(C(C)(C)C)c2)c(N(C)C)n1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
RAB9A P51151 5/20 0.39
NPC1 O15118 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.37
SCN10A Q9Y5Y9 1/20 0.36
SORT1 Q99523 2/20 0.36
TP53 P04637 2/20 0.34
MAPT P10636 2/20 0.34
LMNA P02545 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PRKCI P41743 1/20 0.34
THRB P10828 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HTT P42858 1/20 0.34
NR1H4 Q96RI1 1/20 0.34
GAA P10253 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6830902 0.82 VCP (0.41) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL6828993 0.81 L3MBTL1 (0.39) MEN1KMT2ARAB9ANPC1SMN1; SMN2
SCHEMBL6829260 0.77 SCN10A (0.63) SCN10A
SCHEMBL7079669 0.71 MEN1 (0.55) MEN1KMT2ASMN1; SMN2TP53THRB
SCHEMBL6676960 0.68 LMNA (0.47) MEN1KMT2ASMN1; SMN2SCN10ATP53
SCHEMBL6649475 0.68 TMPRSS2 (0.47) MEN1KMT2ARAB9ANPC1SMN1; SMN2
SCHEMBL6676886 0.68 APOB (0.46) SORT1L3MBTL1KDM4ENR1H4
SCHEMBL6826008 0.65 SCN10A (0.61) MEN1KMT2ASCN10AL3MBTL1ALDH1A1
SCHEMBL6644346 0.64 PIK3CA (0.39) RAB9ANPC1SMN1; SMN2MAPTLMNA
SCHEMBL6643919 0.64 RAB9A (0.46) MEN1KMT2ARAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004039795-A2 AMIDE COMPOUNDS FOR THE TREATMENT OF HYPERLIPIDEMIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-05-13 WO disclosed